Literature DB >> 3021855

A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application.

C Hamblin, I T Barnett, J R Crowther.   

Abstract

The liquid-phase blocking sandwich ELISA has been evaluated for the serological study of antibodies against foot-and-mouth disease virus (FMDV). The titres recorded for sera from a population of more than 300 British uninfected, unvaccinated cattle which were examined against each of the seven immunologically distinct FMDV types were less than 1 in 40. A positive correlation between ELISA and VN titres was recorded for sera either vaccinated or involved in outbreaks of FMDV. The overall regression between the ELISA/VN data showed that 1 in 16 by VN was equivalent to 1 in 40 by ELISA. Thus ELISA is sensitive, specific and reproducible and results may be directly correlated to those recorded by VN. Serum titres may be interpreted as positive or negative and the number of sera which require retesting would be considerably less than by VN. It is suggested that this ELISA may be used as an alternative to the existing VN test for the quantification of antibodies against FMD virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021855     DOI: 10.1016/0022-1759(86)90442-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease.

Authors:  M J Dus Santos; A Wigdorovitz; E Maradei; O Periolo; E Smitsaart; M V Borca; A M Sadir
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Anti-foot-and-mouth disease virus effects of Chinese herbal kombucha in vivo.

Authors:  Naifang Fu; Juncai Wu; Lv Lv; Jijun He; Shengjun Jiang
Journal:  Braz J Microbiol       Date:  2015-10-09       Impact factor: 2.476

Review 3.  Diagnostic assays developed for the control of foot-and-mouth disease in India.

Authors:  Gaurav Kumar Sharma; Sonalika Mahajan; Rakesh Matura; Saravanan Subramaniam; Rajeev Ranjan; Jitendra Biswal; Manoranjan Rout; Jajati Keshari Mohapatra; Bana Bihari Dash; Aniket Sanyal; Bramhadev Pattnaik
Journal:  World J Virol       Date:  2015-08-12

4.  Foot and mouth disease in the Borana pastoral system, southern Ethiopia and implications for livelihoods and international trade.

Authors:  T Rufael; A Catley; A Bogale; M Sahle; Y Shiferaw
Journal:  Trop Anim Health Prod       Date:  2008-01       Impact factor: 1.559

5.  Evaluation of genetic and non-genetic factors on foot and mouth disease (FMD) virus vaccine-elicited immune response in Hardhenu (Bos taurus x Bos indicus) cattle.

Authors:  B L Pander; R Sharma; S S Dhaka; Ankit Magotra; Kapil Dev
Journal:  Trop Anim Health Prod       Date:  2017-08-16       Impact factor: 1.559

6.  Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.

Authors:  Wei Liu; Junjun Shao; Guanglei Zhang; Yanyan Chang; Sudan Ge; Yue Sun; Zhan Gao; Huiyun Chang
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

7.  B cell epitopes within VP1 of type O foot-and-mouth disease virus for detection of viral antibodies.

Authors:  Shan-dian Gao; Jun-zheng Du; Hui-yun Chang; Guo-zheng Cong; Jun-Jun Shao; Tong Lin; Shuai Song; Qing-ge Xie
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

8.  Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

Authors:  K C McCullough; D Parkinson; J R Crowther
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

9.  Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination.

Authors:  C Hamblin; R P Kitching; A I Donaldson; J R Crowther; I T Barnett
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

Review 10.  Protective immune response against foot-and-mouth disease.

Authors:  K C McCullough; F De Simone; E Brocchi; L Capucci; J R Crowther; U Kihm
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.